C12Y 107/02005
Nitric-oxide reductase
Official title: Nitric-oxide reductase (cytochrome c)(1.7.2.5)
C12Y107/02005 (Nitric-oxide reductase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant microorganism including genetic modification that increases activity of nitric oxide reductase and method of reducing concentration of nitric oxide in sample by using the same10 Feb 2026US 12,545,932 B2Samsung Electronics Co., Ltd.
- Recombinant acetogenic bacterium for the conversion of methane to products20 Nov 2018US 10,131,884 B2Lanzatech New Zealand Limited
- Recombinant microorganism having enhanced ability to remove nitric oxide and use thereof24 Apr 2025US 2025/0129392 A1Samsung Electronics Co., Ltd.
- Recombinant microorganism having enhanced ability to remove nitric oxide and use thereof15 Jun 2023US 2023/0183755 A1Samsung Electronics Co., Ltd.
- Recombinant microorganism including genetic modification that increases activity of nitric oxide reductase and method of reducing concentration of nitric oxide in sample by using the same26 May 2022US 2022/0162650 A1Samsung Electronics Co., Ltd.
- Recombinant acetogenic bacterium for the conversion of methane to products25 Aug 2016US 2016/0244785 A1Lanzatech New Zealand Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.